Publications

A First-in-Patient, Multicenter, Double-Blind, 2-Arm, Placebo-Controlled, Randomized Safety and Tolerability Study of a Novel Oral Drug Candidate, CTP-499, in Chronic Kidney Disease.

PCS499

February 11, 2016

Sabounjian L, Graham P, Wu L, Braman V, Cheng C, Liu J, Shipley J, Neutel J, Dao M.

View Publication

Quantitative analyses of CTP-499 and five major metabolites by core-structure analysis

PCS499

May 28, 2014

Tang X, Bridson G, Ke J, Wu L, Erol H, Graham P, Lin CH, Braman V, Zhao H, Liu JF, Lin ZJ, Cheng C.

View Publication

A Randomized Phase I Evaluation of CTP-499, a Novel Deuterium-Containing Drug Candidate for Diabetic Nephropathy

PCS499

February 21, 2013

Braman V, Graham P, Cheng C, Turnquist D, Harnett M, Sabounjian L, Shipley J.

View Publication